Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Korea-U.S. Free Trade Talks Extended; Korean Media Speculates Pharma Revisions

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Negotiators from South Korea and the U.S. are extending the second round of talks, aimed at revising a bilateral free trade agreement pact agreed upon three years ago, until Dec. 2 in the U.S. The deadline extension has triggered speculation in Seoul that the Korean negotiators might call for a revision of the FTA's pharma section in return for a compromise on the thorniest issue surrounding U.S. car exports to Korea

Latest Headlines
See All
UsernamePublicRestriction

Register

SC073852

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel